Acacia Pharma Launches BYFAVO™ (remimazolam) in the United States for Procedural Sedation in Adults Undergoing Medical Procedures Lasting 30 Minutes or Less January 28, 2021
Citrine Medicine Announces Strategic Partnership to bring Alkindi® to China for Use in Pediatric Congenital Adrenal Hyperplasia (CAH) January 27, 2021
Hurdle Raises $5 Million Series Seed to Accelerate Expansion of its Mental Health Platform with Special Focus on the Black Community January 25, 2021
Ultragenyx Announces FDA Clearance of Investigational New Drug (IND) Application for UX701, a New Gene Therapy for the Treatment of Wilson Disease January 21, 2021